Fingerprint
Dive into the research topics of 'Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically